Torben Ek

Goeteborg, O 41650, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial.

Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 27, 2026

Allopurinol increases DNA-thioguanine nucleotides during maintenance therapy in pediatric acute lymphoblastic leukemia.

Allopurinol increases DNA-thioguanine nucleotides during maintenance therapy in pediatric acute lymphoblastic leukemia.

Journal: Haematologica

Published: September 29, 2025

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 14, 2025

Patient-specific sequencing panels enable sensitive circulating tumor DNA analysis in rhabdomyosarcoma independent of genetic profile.

Patient-specific sequencing panels enable sensitive circulating tumor DNA analysis in rhabdomyosarcoma independent of genetic profile.

Journal: NPJ precision oncology

Published: April 24, 2025

Corrigendum to "Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial" [Eur J Cancer 192 (2023) 113260].

Corrigendum to "Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial" [Eur J Cancer 192 (2023) 113260].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 19, 2025

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma.

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma.

Journal: Biomarker research

Published: September 06, 2024

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Journal: Cancer research communications

Published: June 20, 2024

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Journal: Genes, chromosomes & cancer

Published: June 03, 2024

Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.

Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.

Journal: American journal of medical genetics. Part A

Published: January 23, 2024

Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the Sacrum.

Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the Sacrum.

Journal: Sarcoma

Published: December 06, 2023

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Journal: The Lancet regional health. Europe

Published: November 20, 2023

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden.

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden.

Journal: Frontiers in oncology

Published: November 17, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026